Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nengzhi Pang
Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer
Journal of Cancer
Oncology
Related publications
Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer
Cancer Research
Cancer Research
Oncology
Glucosylated Epigallocatechin Gallate (EGCG) Derivatives Combined With EGFR Tyrosine Kinase Inhibitor Overcome Resistance in EGFR T790M Mutant Lung Cancer
Biomedical Journal of Scientific & Technical Research
Proteogenomic Systems Analysis Identifies Targeted Therapy Resistance Mechanisms in EGFR-mutated Lung Cancer
International Journal of Cancer
Cancer Research
Oncology
Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer
Oncology Letters
Cancer Research
Oncology
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Cancer Research
Cancer Research
Oncology
Mechanisms and Strategies to Overcome Resistance to Molecularly Targeted Therapy for Melanoma
Cancer
Cancer Research
Oncology
Drugs Join Forces to Overcome Lung Cancer Resistance
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Lung Adenocarcinoma: Guiding EGFR-targeted Therapy and Beyond
Modern Pathology
Forensic Medicine
Pathology
WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
